Related Experiment Video
Updated: May 26, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Thalidomide: an old drug with new action.
1Department of Cancer Biology and Genetics, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. vij_tox@yahoo.com
Journal of Chemotherapy (Florence, Italy)
|January 12, 2012
Summary
Thalidomide, once withdrawn, is now a vital anticancer and immunomodulatory drug. This review highlights its immune-modulating effects in diverse diseases, including infections and cancer.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Thalidomide has a complex history, initially withdrawn but now repurposed as a potent anticancer and immunomodulatory agent.
- Its precise mechanisms of action across various diseases, including hematologic malignancies, solid tumors, infections, and inflammatory conditions, remain incompletely understood.
- The immune system's critical role in both infectious and non-infectious inflammatory diseases necessitates research into targeted immunomodulatory agents.
Purpose of the Study:
- To review and highlight the immunomodulatory actions of thalidomide.
- To explore thalidomide's effects in various pathological conditions, including cancers and infections.
- To emphasize the importance of understanding immunomodulatory agents that minimize host damage.
Main Methods:
- Literature review of existing research on thalidomide's immunomodulatory effects.
- Analysis of studies investigating thalidomide's role in different disease contexts.
- Synthesis of information on thalidomide's impact on the immune system.
Main Results:
- Thalidomide exhibits significant immunomodulatory properties.
- Its effects are observed in diverse conditions such as hematologic malignancies, solid tumors, and infectious diseases like pneumonia, tuberculosis, and HIV infection.
- The drug influences inflammatory pathways relevant to both cancer and infection.
Conclusions:
- Thalidomide's immunomodulatory actions are crucial for its therapeutic efficacy in various diseases.
- Further research is needed to fully elucidate its mechanisms and optimize its use.
- Developing targeted immunomodulatory drugs like thalidomide is key to managing complex inflammatory and neoplastic conditions.
Related Concept Videos
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...